Controversial HIV vaccine enters phase III trials amid skepticism.
D016915:AIDS Vaccines; D017326:Clinical Trials, Phase III as Topic; D015195:Drug Design; D015699:HIV Envelope Protein gp120 / Q000276:immunology; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control*; D015497:HIV-1; D006801:Humans; D014765:Viral Vaccines
D016915:AIDS Vaccines; D015699:HIV Envelope Protein gp120; D014765:Viral Vaccines